WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. (2015)

First Author: Boulter L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci76452

PubMed Identifier: 25689248

Publication URI: http://europepmc.org/abstract/MED/25689248

Type: Journal Article/Review

Volume: 125

Parent Publication: The Journal of clinical investigation

Issue: 3

ISSN: 0021-9738